InvestorsHub Logo
Followers 840
Posts 120468
Boards Moderated 18
Alias Born 09/05/2002

Re: whytestocks post# 868

Monday, 03/09/2020 10:05:29 AM

Monday, March 09, 2020 10:05:29 AM

Post# of 1168
BMY/ABBV—Empliciti failed to show statsig-better PFS when added to Revlimid/dexamethasone in first-line MM in phase-3 ELOQUENT-1 study:

https://finance.yahoo.com/news/bristol-myers-squibb-reports-primary-105900628.html

PFS was the primary endpoint. HR and other data have not yet been disclosed.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News